Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natesto ABPM Study in Hypogonadism
NCT04976595Phase 4Unknown
- Sponsor
- Acerus Pharmaceuticals
- Start
- Jul 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of natesto in Hypogonadism, sponsored by Acerus Pharmaceuticals. Status: unknown.
02
Drugs
natesto
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT04976595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04976595.